Intratumoral Ral-binding protein 1 (RalBP1) expression as a potential predictor of bevacizumab treatment efficacy in patients with ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...
Main driver genes and BRCA mutation in Chinese patients with pancreatic adenocarcinoma. Nab-paclitaxel/S-1(AS) versus nab-paclitaxel/gemcitabine(AG) for first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback